TriTAC® Technology
Watch our TriTAC technology unleash the target cell-killing properties of a patient’s own immune system.
Science
Harpoon has created a novel antibody-based drug discovery platform called TriTAC®, which offers a new way to unleash the target cell-killing properties of a patient’s own immune system.
Careers
Harpoon is seeking energetic, passionate scientists and innovators to join our effort.
Recent News
August 10,
2022
Harpoon Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 2,
2022
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences